{"gene":"P2RY1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2015,"finding":"Crystal structures of human P2Y1R revealed two distinct ligand-binding sites: nucleotide antagonist MRS2500 binds within the seven-transmembrane bundle (orthosteric site), while non-nucleotide antagonist BPTU binds an allosteric pocket on the external receptor interface with the lipid bilayer, outside the helical bundle.","method":"X-ray crystallography at 2.7 Å (MRS2500 complex) and 2.2 Å (BPTU complex) resolution","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with two separate complexes, atomic resolution","pmids":["25822790"],"is_preprint":false},{"year":1998,"finding":"P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and platelet shape change; selective P2Y1 antagonists (A3P5PS, A3P5P, A2P5P) blocked Ca2+ increases and shape change but not ADP-induced inhibition of adenylyl cyclase, demonstrating that P2Y1 is coupled to phospholipase C/Ca2+ signaling and is distinct from the P2TAC receptor.","method":"Pharmacological antagonism with selective antagonists in human platelets; cloning from human platelet cDNA library","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — replicated across multiple labs with orthogonal pharmacological and molecular cloning approaches","pmids":["9442040","9639511"],"is_preprint":false},{"year":1998,"finding":"The P2Y1 receptor is necessary to trigger ADP-induced platelet aggregation; P2Y1 selective antagonists blocked Ca2+ mobilization, shape change, and aggregation in platelets, endothelial cells, and P2Y1-transfected Jurkat cells, while having no effect on ADP-induced inhibition of adenylyl cyclase.","method":"Pharmacological antagonism in human platelets, rat brain capillary endothelial cells, and P2Y1-transfected Jurkat cells; receptor cloning and heterologous expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — replicated across multiple cell systems with selective antagonists and heterologous expression","pmids":["9639511","9442040"],"is_preprint":false},{"year":2004,"finding":"Purified human P2Y1 receptor, reconstituted in proteoliposomes with heterotrimeric Gαq β1γ2, stimulates steady-state GTP hydrolysis (Gq activation) upon agonist addition; agonist affinities determined directly show 2MeSADP > ADP >> ATP, and RGS4 and PLCβ1 act as GTPase-activating proteins for Gαq/Gα11 in P2Y1R-containing vesicles.","method":"Reconstitution in proteoliposomes with purified receptor and G proteins; radioligand binding with [3H]MRS2279; steady-state GTP hydrolysis assay","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted system with purified proteins, multiple orthogonal assays","pmids":["14742685"],"is_preprint":false},{"year":2016,"finding":"Molecular dynamics simulations showed that BPTU antagonizes P2Y1R by stabilizing extracellular helix bundles and increasing lipid order, while MRS2500 blocks the ligand-binding site; ADP binding breaks an ionic lock within the receptor and forms a continuous water channel leading to receptor activation.","method":"All-atom molecular dynamics simulations (20 μs total) based on crystal structures","journal":"Angewandte Chemie (International ed. in English)","confidence":"Medium","confidence_rationale":"Tier 1 method quality (structure-based) but computational only without experimental mutagenesis validation in this paper","pmids":["27460867"],"is_preprint":false},{"year":2005,"finding":"P2Y1 desensitization in platelets and 1321N1 cells is mediated by protein kinase C (PKC), not by GRK2 or GRK6, whereas P2Y12 desensitization is GRK-dependent; dominant-negative GRK mutants and siRNA knockdown demonstrated that GRKs phosphorylate P2Y12 but not P2Y1.","method":"Dominant-negative kinase mutant overexpression; siRNA knockdown of GRK2/GRK6; pharmacological PKC inhibition in human platelets and 1321N1 cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (dominant-negative, siRNA, pharmacology) in two cell systems","pmids":["15665114"],"is_preprint":false},{"year":2009,"finding":"P2Y1 receptor internalization and β-arrestin-2 recruitment require phosphorylation of distal C-terminal residues Ser352 and Thr358, while PKC-mediated desensitization depends on proximal C-terminal phosphorylation sites; thus receptor desensitization and internalization are mediated by distinct phosphorylation sites and kinases.","method":"Site-directed mutagenesis of phosphorylation sites; confocal microscopy of fluorescent protein-tagged receptors; ELISA-based cell-surface receptor quantification","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with multiple functional readouts","pmids":["19741005"],"is_preprint":false},{"year":2016,"finding":"After agonist-induced activation, P2Y1 sorts to lysosomes for degradation independent of direct receptor ubiquitination; this sorting is mediated by a YPX3L motif in the second intracellular loop that recruits the adaptor protein ALIX. Depletion of ALIX or mutation of the YPX3L motif inhibits P2Y1 sorting into multivesicular endosomes/lysosomes.","method":"ALIX knockdown; site-directed mutagenesis of YPX3L motif; fluorescence microscopy of GFP-tagged receptor","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis plus protein depletion with imaging readout","pmids":["27301021"],"is_preprint":false},{"year":2010,"finding":"P2Y1 receptor recycling after agonist-induced endocytosis occurs via a slow recycling pathway regulated by Sorting Nexin 1 (SNX1); SNX1 inhibition dramatically increases the rate of P2Y1 recycling, while inhibition of retromer components Vps26/Vps35 has no effect, demonstrating retromer-independent SNX1 regulation.","method":"SNX1 dominant-negative inhibition; siRNA knockdown of retromer components; confocal microscopy tracking of receptor trafficking","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 — multiple knockdown approaches with functional trafficking readout, single lab","pmids":["20070609"],"is_preprint":false},{"year":2001,"finding":"P2Y1 receptor mediates ADP-induced platelet shape change through Rho GTPase pathway: P2Y1 antagonism blocked cytoskeletal translocation of cdc42, rac1, and rhoA, actin polymerization, filopodia formation, and centralization of secretory granules in an integrin αIIbβ3-dependent manner.","method":"Selective P2Y1 antagonist (A2P5P) in electron microscopy and biochemical assays of platelet cytoskeletal protein translocation","journal":"Thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with morphological and biochemical readouts, single lab","pmids":["11341507"],"is_preprint":false},{"year":2005,"finding":"ADP activates Rac GTPase and its effector PAK in platelets via the P2Y1 receptor through a Gq-dependent pathway; P2Y12 receptor alone cannot activate Rac, but secreted ADP potentiates Rac activation by other agonists via P2Y12/Gi; Gβγ subunit scavenger peptide blocked P2Y12-dependent co-activation.","method":"Selective P2Y1/P2Y12 antagonists; Rac activation pull-down assay (PAK-GST); pharmacological inhibition of Gq, Gi, PI3K; Gβγ peptide inhibitor in human platelets","journal":"Journal of thrombosis and haemostasis : JTH","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal pharmacological approaches with specific biochemical readouts, single lab","pmids":["16194206"],"is_preprint":false},{"year":2000,"finding":"P2Y1 receptor couples to Rho/Rho kinase signaling in vascular myocytes: P2Y1 stimulation increases membrane-bound RhoA, promotes actin stress fiber formation inhibited by C3 exoenzyme and Y-27632 (Rho kinase inhibitor), and causes Ca2+ sensitization in aortic rings; transfection confirmed that P2Y1 subtype directly drives Rho kinase-dependent actin reorganization.","method":"Transfection of Swiss 3T3 cells with individual P2Y receptors; RhoA membrane translocation assay; C3 exoenzyme and Y-27632 pharmacology; dominant-negative RhoA expression","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — dominant-negative and pharmacological approaches with functional readouts","pmids":["10843869"],"is_preprint":false},{"year":2005,"finding":"Metabotropic P2Y1 receptors in rat dorsal root ganglion neurons inhibit ionotropic P2X3 receptor-mediated currents; this cross-inhibition is blocked by the G protein inhibitor GDP-β-S and the P2Y1 antagonist MRS2179, but not by pertussis toxin, indicating Gαq/11 (not Gi/o) G protein mediation.","method":"Whole-cell patch-clamp recordings; selective pharmacological inhibitors; G protein inhibitors in cultured rat DRG neurons","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with pharmacological dissection, single lab","pmids":["16181623"],"is_preprint":false},{"year":2006,"finding":"P2Y1 receptor activation in astrocytes triggers regulated glutamate exocytosis via Ca2+ release from internal stores; this process requires TNFα and prostaglandin E2 as co-factors, as blocking either abolishes P2Y1-evoked glutamate release. Astrocytes from TNFα-/- or TNFR1-/- mice show deficient glutamate release and altered Ca2+ signaling.","method":"Total internal fluorescence reflection imaging of labeled vesicles; Ca2+ imaging; knockout mouse astrocytes; pharmacological inhibitors; hippocampal slice recordings","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including imaging, knockout mice, and ex vivo slice recordings","pmids":["16882655"],"is_preprint":false},{"year":2012,"finding":"P2Y1 receptor is the post-junctional receptor mediating fast inhibitory junction potentials (fIJP) in mouse colon; P2ry1-/- mice completely lack fIJPs and purinergic contractile responses; β-NAD and ADP-ribose responses were abolished in P2ry1-/- mice, while ATP and ADP responses were retained, identifying the receptor specificity for enteric purinergic neurotransmission.","method":"Genetic knockout mice (P2ry1-/-); microelectrode recordings; pharmacological dissection; video imaging of colonic transit","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with multiple functional readouts, replicated in related studies","pmids":["22371476"],"is_preprint":false},{"year":2013,"finding":"P2Y1 receptor is the general mechanism of purinergic inhibition throughout the GI tract (antrum and cecum), as confirmed in P2Y1-/- mice which lack purinergic IJPs while preserving nitrergic neurotransmission.","method":"Genetic knockout mice (P2Y1-/-); microelectrode recordings; pharmacological validation with MRS2365 and MRS2500","journal":"Neurogastroenterology and motility","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with electrophysiological functional readout","pmids":["23323764"],"is_preprint":false},{"year":2006,"finding":"P2Y1 receptor activation in hippocampal pyramidal neurons inhibits M-type K+ current (IM) and increases neuronal firing; this is blocked by the selective P2Y1 antagonist MRS2179 and by the M-channel blocker XE991, establishing P2Y1-mediated M-current inhibition as the mechanism underlying nucleotide-induced neuronal excitability.","method":"Whole-cell patch-clamp; selective P2Y1 antagonist MRS2179; immunostaining for P2Y1 in cultured rat hippocampal neurons","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with selective pharmacology, single lab","pmids":["16957090"],"is_preprint":false},{"year":2014,"finding":"Astrocytic hyperactivity in an Alzheimer's disease mouse model is completely normalized by P2Y1 receptor inhibition; astroglial Ca2+ transients and waves are mediated by P2 purinoreceptors, with P2Y1R blockade (but not P2X receptor blockade) normalizing activity; nucleotide release through connexin hemichannels and increasing cortical ADP augments this hyperactivity.","method":"In vivo multiphoton Ca2+ imaging; selective P2Y1R antagonists; P2X vs P2Y pharmacological dissection in AD mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — in vivo imaging with pharmacological dissection, strong phenotypic readout","pmids":["25406732"],"is_preprint":false},{"year":2017,"finding":"Microglia transform astrocytes into a neuroprotective phenotype after traumatic brain injury by secreting cytokines that downregulate P2Y1 receptor expression in astrocytes; astrocyte-specific P2Y1 overexpression counteracted scar formation while P2Y1 knockdown facilitated it, demonstrating P2Y1 as a key regulator of astrocyte phenotype switching.","method":"Astrocyte-specific P2Y1 overexpression and knockdown mouse models; in vitro injury assays; immunostaining; cytokine blocking","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — complementary gain- and loss-of-function genetic models with mechanistic follow-up","pmids":["28494865"],"is_preprint":false},{"year":2014,"finding":"RhoA signaling downstream of platelet P2Y1 receptor (not P2Y12) mediates platelet-dependent leukocyte recruitment during allergic inflammation; P2Y1 activation in platelets induces RhoA activity in vivo, and Rho kinase 1 inhibition in platelets abolished leukocyte chemotaxis, demonstrating a P2Y1-RhoA axis distinct from the P2Y12-hemostasis pathway.","method":"Selective receptor antagonists in vivo; thrombocytopenic mice reconstituted with pharmacologically pretreated platelets; flow cytometry; RhoA activity assay","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo platelet reconstitution with functional readout, single lab","pmids":["25445826"],"is_preprint":false},{"year":2000,"finding":"P2Y1 receptor mediates ADP-induced generation of a p38 MAP kinase-activating factor in human platelets via an aspirin-sensitive pathway; selective P2Y1 antagonist A2P5P inhibited this response while P2TAC and P2X1 antagonists had no effect.","method":"Selective pharmacological antagonists; p38 MAP kinase activation assay in human platelets","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with biochemical kinase activity readout, single lab","pmids":["10759852"],"is_preprint":false},{"year":2015,"finding":"Electrical stimulation of skeletal muscle triggers ROS production via a P2Y1-PKC-NOX2 pathway; extracellular ATP released from muscle activates P2Y1 receptors (MRS2365 mimics effect; P2Y1 antagonist MRS2179 blocks it), leading to PKC-dependent NOX2 activation and H2O2 production.","method":"Selective P2Y1 agonist and antagonist; fluorescent ROS probes; NOX2 and PKC inhibitors in skeletal muscle fibers and isolated muscle fibres","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with functional ROS readout, single lab","pmids":["26053483"],"is_preprint":false},{"year":2014,"finding":"ADP activation of P2Y1 receptor in endothelial cells produces H2O2-dependent phosphorylation of eNOS, AMPK, MARCKS, and c-Abl; H2O2 mediates downstream Rac1-dependent AMPK and CrkII signaling; P2Y1 activation also transactivates the receptor tyrosine kinase Flt3. ADP-stimulated H2O2 increases were localized to cytosol and caveolae.","method":"PEG-catalase H2O2 scavenger; FRET-based Rac1 and H2O2 biosensors (HyPer2) with subcellular targeting; receptor tyrosine kinase screen; pharmacological inhibitors in endothelial cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal biosensor and scavenger approaches, single lab","pmids":["24550450"],"is_preprint":false},{"year":2008,"finding":"Membrane depolarization directly potentiates P2Y1 receptor-evoked IP3-dependent Ca2+ mobilization in megakaryocytes, revealing voltage-dependence of this Gq-coupled GPCR; depolarization can also stimulate Ca2+ release in the presence of competitive antagonists, indicating a novel coincidence detection mechanism.","method":"Simultaneous whole-cell patch-clamp and fura-2 fluorescence in rat megakaryocytes; voltage protocols with multiple agonists and antagonists","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology combined with Ca2+ imaging, single lab","pmids":["18414379"],"is_preprint":false},{"year":1996,"finding":"The cloned human P2Y1 receptor, when stably expressed in 1321N1 astrocytoma cells, activates phospholipase C/inositol phosphate signaling in response to ADP and 2-methylthioATP; adenosine bisphosphate derivatives (A3P5PS, A3P5P, A2P5P) act as competitive antagonists of this receptor without affecting P2Y2, P2Y4, or P2Y6 receptors.","method":"Heterologous expression; inositol phosphate accumulation assay; Schild analysis of competitive antagonism","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — heterologous expression with quantitative pharmacological characterization, replicated across labs","pmids":["8913364"],"is_preprint":false},{"year":2004,"finding":"NTPDase1 (hydrolyzes both NTPs and NDPs) reduces P2Y1 receptor signaling by degrading agonist ADP, while NTPDase2 (preferentially hydrolyzes NTPs) converts ATP to ADP, thereby increasing basal P2Y1 receptor activity; co-expression or co-culture of these ectonucleotidases differentially modulates the EC50 for P2Y1 receptor agonists.","method":"Co-expression and co-culture of P2Y1R with NTPDase1 or NTPDase2 in cell lines; inositol phosphate accumulation assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — cell co-expression and co-culture approaches with functional readout, single lab","pmids":["15496502"],"is_preprint":false},{"year":2003,"finding":"P2Y1 receptor and NTPDase1/CD39 are co-localized within caveolae of human placental endothelial cells, suggesting that the ectonucleotidase directly controls local nucleotide concentration and P2Y1 receptor activation at these membrane microdomains.","method":"Immunohistochemistry and immunogold electron microscopy of human placental tissue","journal":"European journal of histochemistry : EJH","confidence":"Low","confidence_rationale":"Tier 3 — co-localization by immunomicroscopy without functional validation of the microdomains","pmids":["15590415"],"is_preprint":false},{"year":2011,"finding":"P2Y1 receptor activation induces apoptosis and inhibits proliferation of PC-3 prostate cancer cells through the MAP kinase pathway; selective P2Y1 agonist MRS2365 activated caspase-3 and increased LDH release, effects blocked by P2Y1 antagonist MRS2500, P2Y1 siRNA, and the MAP kinase inhibitor PD98059.","method":"Selective agonist/antagonist; siRNA knockdown; caspase-3 assay; LDH release; annexin-V staining; MTT proliferation assay in PC-3 cells","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological, genetic, and biochemical approaches with multiple death readouts","pmids":["21632028"],"is_preprint":false},{"year":2003,"finding":"Transgenic mice overexpressing P2Y1 receptor specifically in megakaryocytes/platelets (84% increase in receptor density) display platelet hyper-reactivity: enhanced aggregation to ADP and low-dose collagen, ADP-induced granule secretion (not seen in wild-type), shortened bleeding time, and increased sensitivity to in vivo thromboembolism.","method":"Platelet-lineage-specific transgenic overexpression; saturation binding assay; aggregometry; in vivo thromboembolism model","journal":"Journal of thrombosis and haemostasis : JTH","confidence":"High","confidence_rationale":"Tier 2 — genetic gain-of-function model with multiple in vitro and in vivo functional readouts","pmids":["12871553"],"is_preprint":false},{"year":2011,"finding":"P2Y1 receptor is required for normal thermal sensitivity in cutaneous polymodal nociceptors (CPMs); P2Y1-/- mice show increased mean heat threshold and decreased peak firing during thermal ramps, and altered cold threshold, without changes in mechanical sensitivity.","method":"Genetic knockout mice (P2Y1-/-); ex vivo electrophysiological recordings from skin-nerve-DRG preparation with calibrated thermal stimuli","journal":"Molecular pain","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with specific ex vivo electrophysiological readout, single lab","pmids":["21310055"],"is_preprint":false},{"year":2014,"finding":"Uridine adenosine tetraphosphate (Up4A) is a potent native agonist for P2Y1R and small-conductance K+ (SK) channel activation in human and mouse colon; Up4A-induced relaxation and hyperpolarization were blocked by the P2Y1R antagonist MRS2500 and were absent in P2ry1-/- mice, and Up4A responses are not mediated by its metabolites.","method":"Selective P2Y1R antagonist MRS2500; P2ry1-/- genetic knockout mice; electrophysiology; Ca2+ imaging in P2Y1R-expressing astrocytoma cells; HPLC for metabolite analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — pharmacology, genetic knockout, and direct biochemical approaches across multiple preparations","pmids":["25341729"],"is_preprint":false},{"year":2009,"finding":"ATP released from skeletal muscle during electrical stimulation inhibits chloride channels via P2Y1 receptors: the P2Y1-selective agonist 2MeSADP (EC50 ~160 nM) increased input resistance and prolonged mEPP falling phase; these effects were blocked by the P2Y1 antagonist MRS2179 and anthracene-9-carboxylic acid (Cl- channel blocker).","method":"Intracellular microelectrode recordings in innervated rat muscle; selective P2Y1 agonist and antagonist; chloride channel pharmacology","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with selective pharmacological dissection, single lab","pmids":["19805741"],"is_preprint":false},{"year":2003,"finding":"P2Y12 receptor (not P2Y1) is involved in thrombin-induced phosphatidylserine exposure on platelets and subsequent thrombin generation in platelet-rich plasma; P2Y1 is not involved in procoagulant activity, but both receptors contribute to platelet-leukocyte interactions mediated by P-selectin exposure.","method":"Selective P2Y1 (MRS2179) and P2Y12 (AR-C69931MX) antagonists; flow cytometry for PS exposure; thrombin generation assay; P-selectin assay in human platelets","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with selective antagonists and multiple functional assays, single lab","pmids":["12933533"],"is_preprint":false}],"current_model":"P2Y1R is a Gq-coupled GPCR activated by extracellular ADP (and other nucleotides like Up4A) that signals through phospholipase C to mobilize intracellular Ca2+ and activate downstream effectors including PKC, Rac GTPase, RhoA/Rho-kinase, p38 MAPK, and H2O2-dependent pathways; crystal structures reveal two distinct ligand-binding sites (an orthosteric transmembrane site and an allosteric exterior lipid-bilayer interface), receptor desensitization is controlled by PKC phosphorylation of proximal C-terminal sites, internalization by GRK-independent phosphorylation of distal C-terminal residues Ser352/Thr358 and β-arrestin-2 recruitment, and lysosomal degradation via ALIX/YPX3L motif; physiologically, P2Y1R is essential for ADP-induced platelet shape change, Ca2+ mobilization, and aggregation, mediates fast inhibitory purinergic neuromuscular transmission in the GI tract, regulates astrocyte Ca2+ dynamics and phenotype switching in the brain, modulates thermal nociception in sensory neurons, and controls M-current and neuronal excitability in hippocampal neurons."},"narrative":{"teleology":[{"year":1996,"claim":"Identifying that the cloned human P2Y1 receptor couples to phospholipase C/inositol phosphate signaling upon ADP stimulation, and that adenosine bisphosphate derivatives serve as selective competitive antagonists, established the receptor's pharmacological identity and Gq-PLC coupling.","evidence":"Heterologous expression in 1321N1 astrocytoma cells with inositol phosphate accumulation and Schild analysis","pmids":["8913364"],"confidence":"High","gaps":["Endogenous cellular functions not yet demonstrated","G protein specificity not directly tested"]},{"year":1998,"claim":"Demonstrating that P2Y1 mediates ADP-induced Ca2+ mobilization, platelet shape change, and aggregation—while having no role in adenylyl cyclase inhibition—resolved the long-standing question of which receptor subtype drives the initial phase of platelet activation and separated P2Y1 from the P2TAC/P2Y12 pathway.","evidence":"Selective P2Y1 antagonists in human platelets, endothelial cells, and P2Y1-transfected Jurkat cells; platelet cDNA cloning","pmids":["9442040","9639511"],"confidence":"High","gaps":["Knockout validation not yet available","Signaling intermediates between Gq and cytoskeletal reorganization uncharacterized"]},{"year":2000,"claim":"Establishing that P2Y1 couples to RhoA/Rho kinase–dependent actin remodeling and to p38 MAPK activation in platelets and vascular myocytes expanded the downstream signaling repertoire beyond PLC/Ca2+ to include cytoskeletal and stress kinase pathways.","evidence":"Transfection of individual P2Y receptors in Swiss 3T3 cells; RhoA membrane translocation; dominant-negative RhoA; Rho kinase inhibitor pharmacology; p38 MAPK activity in human platelets","pmids":["10843869","10759852"],"confidence":"Medium","gaps":["Direct biochemical link between Gαq and RhoA activation not delineated","p38 activation mechanism (aspirin-sensitive factor) not molecularly identified"]},{"year":2001,"claim":"Showing that P2Y1 antagonism blocks ADP-induced translocation of Cdc42, Rac1, and RhoA to the platelet cytoskeleton along with filopodia formation linked the receptor to the full Rho-family GTPase cascade governing platelet shape change.","evidence":"Electron microscopy and biochemical cytoskeletal fractionation with selective P2Y1 antagonist in human platelets","pmids":["11341507"],"confidence":"Medium","gaps":["Integrin dependence versus independence of each GTPase step unclear","No genetic loss-of-function confirmation"]},{"year":2003,"claim":"Platelet-lineage-specific P2Y1 transgenic overexpression causing hyper-reactivity, enhanced aggregation, granule secretion, shortened bleeding time, and increased thromboembolism provided the first genetic gain-of-function proof that P2Y1 receptor density directly controls thrombotic risk in vivo.","evidence":"Megakaryocyte/platelet-specific transgenic mice; saturation binding; aggregometry; in vivo thromboembolism model","pmids":["12871553"],"confidence":"High","gaps":["Corresponding loss-of-function platelet phenotype not shown in this study","Whether increased receptor density shifts agonist preference unexamined"]},{"year":2004,"claim":"Reconstituting purified P2Y1R with Gαq/β1γ2 in proteoliposomes and measuring agonist-stimulated GTP hydrolysis provided direct biochemical proof of Gq coupling, established the intrinsic agonist rank order (2MeSADP > ADP >> ATP), and showed RGS4 and PLCβ1 function as GAPs for Gαq in this system.","evidence":"Purified receptor reconstitution in proteoliposomes; radioligand binding; steady-state GTPase assay","pmids":["14742685"],"confidence":"High","gaps":["Structural basis of agonist selectivity not resolved","Other potential G protein couplings not tested in reconstituted system"]},{"year":2005,"claim":"Dissecting P2Y1 desensitization as PKC-dependent (not GRK-dependent) using dominant-negative GRKs and siRNA, in contrast to GRK-dependent P2Y12 desensitization, established that the two platelet ADP receptors use fundamentally different regulatory mechanisms.","evidence":"Dominant-negative GRK2/GRK6 overexpression; GRK siRNA knockdown; PKC inhibitors in platelets and 1321N1 cells","pmids":["15665114"],"confidence":"High","gaps":["Specific PKC isoform responsible not identified","Phosphorylation sites mediating PKC desensitization not mapped"]},{"year":2005,"claim":"Demonstrating that P2Y1 activates Rac GTPase and PAK through Gq while P2Y12 potentiates this via Gi/Gβγ resolved how two ADP receptors cooperate to achieve full small GTPase activation during platelet signaling.","evidence":"Selective P2Y1/P2Y12 antagonists; Rac-GTP pull-down; Gβγ scavenger peptide in human platelets","pmids":["16194206"],"confidence":"Medium","gaps":["Intermediate between Gαq and Rac guanine nucleotide exchange factor not identified","Relative contributions to platelet spreading versus aggregation unclear"]},{"year":2006,"claim":"Finding that P2Y1 activation in astrocytes triggers Ca2+-dependent glutamate exocytosis requiring TNFα and prostaglandin E2 as co-factors, and that P2Y1 inhibits M-type K+ current in hippocampal neurons to increase excitability, established two distinct neuronal circuit–level roles for P2Y1 signaling in the brain.","evidence":"TIRFM vesicle imaging and Ca2+ imaging in astrocytes from TNFα−/− and TNFR1−/− mice; whole-cell patch-clamp with MRS2179 in hippocampal neurons","pmids":["16882655","16957090"],"confidence":"High","gaps":["Identity of the gliotransmitter release machinery downstream of Ca2+ not fully defined","Whether M-current modulation occurs in vivo not shown"]},{"year":2009,"claim":"Mapping P2Y1 internalization to distal C-terminal phosphorylation sites Ser352/Thr358 and β-arrestin-2 recruitment—distinct from the proximal PKC sites controlling desensitization—demonstrated that functional uncoupling and endocytic removal are mechanistically separable regulatory events.","evidence":"Site-directed mutagenesis; confocal microscopy of fluorescent-tagged receptor; ELISA-based surface quantification","pmids":["19741005"],"confidence":"High","gaps":["The kinase phosphorylating Ser352/Thr358 not identified (shown to be GRK-independent)","β-arrestin-2 binding determinants on receptor not mapped"]},{"year":2010,"claim":"Identifying SNX1 as a retromer-independent regulator of P2Y1 slow recycling revealed a non-canonical post-endocytic trafficking pathway for this receptor.","evidence":"SNX1 dominant-negative inhibition; siRNA knockdown of retromer components; confocal receptor tracking","pmids":["20070609"],"confidence":"Medium","gaps":["Mechanism by which SNX1 retards recycling not defined","Not validated in endogenous P2Y1-expressing primary cells"]},{"year":2012,"claim":"Complete loss of fast inhibitory junction potentials in P2ry1−/− mouse colon, and extension to antrum and cecum, established P2Y1 as the obligate post-junctional receptor for purinergic inhibitory neuromuscular transmission throughout the gastrointestinal tract, with β-NAD and ADP-ribose (not ATP) as likely endogenous transmitters.","evidence":"P2ry1−/− knockout mice; microelectrode recordings; pharmacological dissection; video imaging of colonic transit","pmids":["22371476","23323764"],"confidence":"High","gaps":["Endogenous purinergic neurotransmitter identity debated (β-NAD vs. ADP-ribose)","Mechanism of SK channel coupling downstream of P2Y1 in smooth muscle not fully resolved"]},{"year":2014,"claim":"Multiple 2014 studies expanded the physiological scope: Up4A was identified as a potent endogenous P2Y1 agonist for enteric inhibitory neurotransmission; P2Y1-RhoA signaling in platelets was shown to drive leukocyte recruitment in allergic inflammation; P2Y1-mediated H2O2 production was established as a second messenger activating AMPK, Rac1, and Flt3 transactivation in endothelial cells; and P2Y1 blockade normalized astrocytic hyperactivity in an Alzheimer's disease mouse model.","evidence":"P2ry1−/− mice with electrophysiology and HPLC; platelet reconstitution in thrombocytopenic mice; FRET-based H2O2/Rac1 biosensors in endothelial cells; in vivo multiphoton Ca2+ imaging in AD model","pmids":["25341729","25445826","24550450","25406732"],"confidence":"High","gaps":["Source of Up4A in enteric nervous system not identified","Whether H2O2-dependent signaling occurs in platelets or only endothelium unknown","Causal relationship between P2Y1 and Alzheimer's pathogenesis not established"]},{"year":2015,"claim":"Crystal structures of P2Y1R bound to a nucleotide antagonist (orthosteric) and a non-nucleotide antagonist (allosteric, at the lipid-bilayer interface) revealed two pharmacologically distinct binding sites, providing the first atomic-resolution framework for structure-based drug design targeting this receptor class.","evidence":"X-ray crystallography at 2.7 Å and 2.2 Å resolution","pmids":["25822790"],"confidence":"High","gaps":["No agonist-bound or active-state structure available","Structural basis for Gq selectivity not resolved"]},{"year":2016,"claim":"Identifying the ALIX-binding YPX3L motif in the second intracellular loop as required for ubiquitin-independent lysosomal sorting completed the post-endocytic trafficking itinerary from internalization through degradation.","evidence":"ALIX knockdown; YPX3L motif mutagenesis; GFP-tagged receptor fluorescence microscopy","pmids":["27301021"],"confidence":"High","gaps":["Whether lysosomal sorting is the dominant degradation route in primary cells not confirmed","Interaction between SNX1-recycling and ALIX-degradation pathways not examined"]},{"year":2017,"claim":"Demonstrating that microglial cytokines downregulate astrocytic P2Y1 to promote scar formation after brain injury, with P2Y1 overexpression counteracting and knockdown facilitating scarring, established P2Y1 as a central switch governing astrocyte phenotype in neuroinflammation.","evidence":"Astrocyte-specific P2Y1 overexpression and knockdown mouse models; in vitro injury assays; cytokine blocking","pmids":["28494865"],"confidence":"High","gaps":["Downstream transcriptional program controlled by P2Y1 in reactive astrocytes not mapped","Whether this mechanism operates in chronic neurodegenerative disease unknown"]},{"year":null,"claim":"No agonist-bound active-state structure of P2Y1R exists, the kinase phosphorylating the distal C-terminal internalization sites remains unidentified, the precise endogenous purinergic neurotransmitter at enteric P2Y1 receptors is debated, and the structural basis for Gq selectivity over other G proteins has not been determined.","evidence":"","pmids":[],"confidence":"High","gaps":["Active-state crystal or cryo-EM structure needed","Identity of kinase for Ser352/Thr358 phosphorylation unknown","Endogenous enteric neurotransmitter (β-NAD, ADP-ribose, or Up4A) not definitively established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,2,3,24,30]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,6,26]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[7]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[7,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,3,11,12,24]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[1,2,9,10,28]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[14,15,16,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[19]}],"complexes":[],"partners":["GNA11","GNAQ","ARRB2","ALIX","SNX1","RHOA","RAC1","PLCB1"],"other_free_text":[]},"mechanistic_narrative":"P2RY1 encodes a Gq-coupled purinergic receptor activated by extracellular ADP and uridine adenosine tetraphosphate (Up4A) that signals through phospholipase C to mobilize intracellular Ca2+ and engage downstream effectors including PKC, RhoA/Rho kinase, Rac GTPase, p38 MAPK, and H2O2-dependent pathways [PMID:9442040, PMID:14742685, PMID:10843869, PMID:24550450, PMID:25341729]. Crystal structures reveal two pharmacologically distinct antagonist-binding sites—an orthosteric pocket within the transmembrane bundle and an allosteric site at the receptor–lipid bilayer interface—while receptor desensitization is controlled by PKC phosphorylation of proximal C-terminal residues and internalization requires GRK-independent phosphorylation of Ser352/Thr358 with β-arrestin-2 recruitment, followed by ALIX/YPX3L motif–dependent lysosomal sorting [PMID:25822790, PMID:15665114, PMID:19741005, PMID:27301021]. Physiologically, P2RY1 is essential for ADP-induced platelet shape change and aggregation, mediates fast inhibitory purinergic neurotransmission throughout the gastrointestinal tract, regulates astrocyte Ca2+ dynamics and phenotype switching in the brain, modulates thermal nociception in sensory neurons, and controls M-current–dependent neuronal excitability in hippocampal neurons [PMID:9639511, PMID:22371476, PMID:25406732, PMID:28494865, PMID:21310055, PMID:16957090]."},"prefetch_data":{"uniprot":{"accession":"P47900","full_name":"P2Y purinoceptor 1","aliases":["ADP receptor","Purinergic receptor"],"length_aa":373,"mass_kda":42.1,"function":"Receptor for extracellular adenine nucleotides such as ADP (PubMed:25822790, PubMed:9038354, PubMed:9442040). In platelets, binding to ADP leads to mobilization of intracellular calcium ions via activation of phospholipase C, a change in platelet shape, and ultimately platelet aggregation (PubMed:9442040)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P47900/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P2RY1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P2RY1","total_profiled":1310},"omim":[{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"},{"mim_id":"618925","title":"G PROTEIN-COUPLED RECEPTOR 171; GPR171","url":"https://www.omim.org/entry/618925"},{"mim_id":"602697","title":"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11; P2RY11","url":"https://www.omim.org/entry/602697"},{"mim_id":"602451","title":"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6; P2RY6","url":"https://www.omim.org/entry/602451"},{"mim_id":"601167","title":"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1; P2RY1","url":"https://www.omim.org/entry/601167"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"placenta","ntpm":23.9}],"url":"https://www.proteinatlas.org/search/P2RY1"},"hgnc":{"alias_symbol":["P2Y1","SARCC"],"prev_symbol":[]},"alphafold":{"accession":"P47900","domains":[{"cath_id":"1.20.1070.10","chopping":"50-327","consensus_level":"high","plddt":93.6659,"start":50,"end":327}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P47900","model_url":"https://alphafold.ebi.ac.uk/files/AF-P47900-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P47900-F1-predicted_aligned_error_v6.png","plddt_mean":85.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P2RY1","jax_strain_url":"https://www.jax.org/strain/search?query=P2RY1"},"sequence":{"accession":"P47900","fasta_url":"https://rest.uniprot.org/uniprotkb/P47900.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P47900/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P47900"}},"corpus_meta":[{"pmid":"9442040","id":"PMC_9442040","title":"Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9442040","citation_count":377,"is_preprint":false},{"pmid":"25822790","id":"PMC_25822790","title":"Two disparate ligand-binding sites in the human P2Y1 receptor.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25822790","citation_count":287,"is_preprint":false},{"pmid":"28494865","id":"PMC_28494865","title":"Transformation of Astrocytes to a Neuroprotective Phenotype by Microglia via P2Y1 Receptor Downregulation.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28494865","citation_count":274,"is_preprint":false},{"pmid":"25406732","id":"PMC_25406732","title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25406732","citation_count":260,"is_preprint":false},{"pmid":"8913364","id":"PMC_8913364","title":"Identification of competitive antagonists of the P2Y1 receptor.","date":"1996","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8913364","citation_count":225,"is_preprint":false},{"pmid":"9639511","id":"PMC_9639511","title":"The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9639511","citation_count":206,"is_preprint":false},{"pmid":"16882655","id":"PMC_16882655","title":"P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16882655","citation_count":176,"is_preprint":false},{"pmid":"28644440","id":"PMC_28644440","title":"LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28644440","citation_count":136,"is_preprint":false},{"pmid":"15665114","id":"PMC_15665114","title":"P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15665114","citation_count":132,"is_preprint":false},{"pmid":"16581111","id":"PMC_16581111","title":"Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.","date":"2006","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/16581111","citation_count":123,"is_preprint":false},{"pmid":"9547364","id":"PMC_9547364","title":"ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.","date":"1998","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9547364","citation_count":117,"is_preprint":false},{"pmid":"14564529","id":"PMC_14564529","title":"Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat.","date":"2003","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14564529","citation_count":115,"is_preprint":false},{"pmid":"8579591","id":"PMC_8579591","title":"Cloning and chromosomal localization of the human P2Y1 purinoceptor.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8579591","citation_count":115,"is_preprint":false},{"pmid":"9457242","id":"PMC_9457242","title":"Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.","date":"1998","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9457242","citation_count":111,"is_preprint":false},{"pmid":"12933533","id":"PMC_12933533","title":"Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12933533","citation_count":108,"is_preprint":false},{"pmid":"14673009","id":"PMC_14673009","title":"Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14673009","citation_count":106,"is_preprint":false},{"pmid":"22371476","id":"PMC_22371476","title":"P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit.","date":"2012","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22371476","citation_count":104,"is_preprint":false},{"pmid":"15514209","id":"PMC_15514209","title":"Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.","date":"2004","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15514209","citation_count":100,"is_preprint":false},{"pmid":"14742685","id":"PMC_14742685","title":"Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14742685","citation_count":98,"is_preprint":false},{"pmid":"11674863","id":"PMC_11674863","title":"Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.","date":"2001","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/11674863","citation_count":96,"is_preprint":false},{"pmid":"29724785","id":"PMC_29724785","title":"P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29724785","citation_count":92,"is_preprint":false},{"pmid":"10843869","id":"PMC_10843869","title":"P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843869","citation_count":88,"is_preprint":false},{"pmid":"8630005","id":"PMC_8630005","title":"Cloning and tissue distribution of the human P2Y1 receptor.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8630005","citation_count":82,"is_preprint":false},{"pmid":"12970084","id":"PMC_12970084","title":"P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12970084","citation_count":82,"is_preprint":false},{"pmid":"15345752","id":"PMC_15345752","title":"Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.","date":"2004","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15345752","citation_count":78,"is_preprint":false},{"pmid":"11754592","id":"PMC_11754592","title":"Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.","date":"2002","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11754592","citation_count":76,"is_preprint":false},{"pmid":"26053483","id":"PMC_26053483","title":"ROS Production via P2Y1-PKC-NOX2 Is Triggered by Extracellular ATP after Electrical Stimulation of Skeletal Muscle Cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26053483","citation_count":71,"is_preprint":false},{"pmid":"26973243","id":"PMC_26973243","title":"Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26973243","citation_count":65,"is_preprint":false},{"pmid":"18596227","id":"PMC_18596227","title":"A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18596227","citation_count":64,"is_preprint":false},{"pmid":"25445826","id":"PMC_25445826","title":"RhoA signaling through platelet P2Y₁ receptor controls leukocyte recruitment in allergic mice.","date":"2014","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25445826","citation_count":60,"is_preprint":false},{"pmid":"19781676","id":"PMC_19781676","title":"Low-intensity pulsed ultrasound-dependent osteoblast proliferation occurs by via activation of the P2Y receptor: role of the P2Y1 receptor.","date":"2009","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19781676","citation_count":60,"is_preprint":false},{"pmid":"19906120","id":"PMC_19906120","title":"P2Y(1) receptors mediate inhibitory neuromuscular transmission in the rat colon.","date":"2009","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19906120","citation_count":59,"is_preprint":false},{"pmid":"11004484","id":"PMC_11004484","title":"Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11004484","citation_count":58,"is_preprint":false},{"pmid":"19637098","id":"PMC_19637098","title":"Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.","date":"2009","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/19637098","citation_count":56,"is_preprint":false},{"pmid":"10229631","id":"PMC_10229631","title":"Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.","date":"1999","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10229631","citation_count":56,"is_preprint":false},{"pmid":"15888248","id":"PMC_15888248","title":"P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.","date":"2005","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15888248","citation_count":56,"is_preprint":false},{"pmid":"17559347","id":"PMC_17559347","title":"Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.","date":"2007","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/17559347","citation_count":56,"is_preprint":false},{"pmid":"18310463","id":"PMC_18310463","title":"New evidence for purinergic signaling in the olfactory bulb: A2A and P2Y1 receptors mediate intracellular calcium release in astrocytes.","date":"2008","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/18310463","citation_count":54,"is_preprint":false},{"pmid":"20962269","id":"PMC_20962269","title":"P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20962269","citation_count":51,"is_preprint":false},{"pmid":"11117494","id":"PMC_11117494","title":"Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease.","date":"2000","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/11117494","citation_count":51,"is_preprint":false},{"pmid":"9517568","id":"PMC_9517568","title":"ATP-induced arachidonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors.","date":"1998","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/9517568","citation_count":51,"is_preprint":false},{"pmid":"27301021","id":"PMC_27301021","title":"ALIX Regulates the Ubiquitin-Independent Lysosomal Sorting of the P2Y1 Purinergic Receptor via a YPX3L Motif.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27301021","citation_count":49,"is_preprint":false},{"pmid":"29490276","id":"PMC_29490276","title":"P2RY1/ALK3-Expressing Cells within the Adult Human Exocrine Pancreas Are BMP-7 Expandable and Exhibit Progenitor-like Characteristics.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29490276","citation_count":48,"is_preprint":false},{"pmid":"11159687","id":"PMC_11159687","title":"Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.","date":"2001","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11159687","citation_count":48,"is_preprint":false},{"pmid":"18502966","id":"PMC_18502966","title":"Mechanical stress induces osteopontin via ATP/P2Y1 in periodontal cells.","date":"2008","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/18502966","citation_count":48,"is_preprint":false},{"pmid":"12595918","id":"PMC_12595918","title":"The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179.","date":"2003","source":"Cardiovascular drug reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12595918","citation_count":47,"is_preprint":false},{"pmid":"16181623","id":"PMC_16181623","title":"Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons.","date":"2005","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16181623","citation_count":47,"is_preprint":false},{"pmid":"27460867","id":"PMC_27460867","title":"The Molecular Mechanism of P2Y1 Receptor Activation.","date":"2016","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/27460867","citation_count":46,"is_preprint":false},{"pmid":"20070609","id":"PMC_20070609","title":"Regulation of P2Y1 receptor traffic by sorting Nexin 1 is retromer independent.","date":"2010","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/20070609","citation_count":46,"is_preprint":false},{"pmid":"11341507","id":"PMC_11341507","title":"Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.","date":"2001","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/11341507","citation_count":45,"is_preprint":false},{"pmid":"12871553","id":"PMC_12871553","title":"Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice.","date":"2003","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/12871553","citation_count":45,"is_preprint":false},{"pmid":"17672857","id":"PMC_17672857","title":"Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus.","date":"2007","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17672857","citation_count":42,"is_preprint":false},{"pmid":"10759852","id":"PMC_10759852","title":"The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10759852","citation_count":41,"is_preprint":false},{"pmid":"22137295","id":"PMC_22137295","title":"Purinergic receptor P2Y1 regulates polymodal C-fiber thermal thresholds and sensory neuron phenotypic switching during peripheral inflammation.","date":"2011","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/22137295","citation_count":40,"is_preprint":false},{"pmid":"16934758","id":"PMC_16934758","title":"Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.","date":"2006","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16934758","citation_count":40,"is_preprint":false},{"pmid":"25449358","id":"PMC_25449358","title":"Participation of peripheral P2Y1, P2Y6 and P2Y11 receptors in formalin-induced inflammatory pain in rats.","date":"2014","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/25449358","citation_count":40,"is_preprint":false},{"pmid":"16194206","id":"PMC_16194206","title":"A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation.","date":"2005","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/16194206","citation_count":40,"is_preprint":false},{"pmid":"20067476","id":"PMC_20067476","title":"The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.","date":"2010","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20067476","citation_count":39,"is_preprint":false},{"pmid":"21632028","id":"PMC_21632028","title":"Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.","date":"2011","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21632028","citation_count":39,"is_preprint":false},{"pmid":"16957090","id":"PMC_16957090","title":"Activation of P2Y1 nucleotide receptors induces inhibition of the M-type K+ current in rat hippocampal pyramidal neurons.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16957090","citation_count":37,"is_preprint":false},{"pmid":"29305530","id":"PMC_29305530","title":"Role of Purinergic Receptor P2Y1 in Spatiotemporal Ca2+ Dynamics in Astrocytes.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29305530","citation_count":36,"is_preprint":false},{"pmid":"9154346","id":"PMC_9154346","title":"An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.","date":"1997","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9154346","citation_count":36,"is_preprint":false},{"pmid":"31048325","id":"PMC_31048325","title":"Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y1 Receptor in Experimental Epilepsy.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31048325","citation_count":36,"is_preprint":false},{"pmid":"11336535","id":"PMC_11336535","title":"P2y1 and P2y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells.","date":"2001","source":"Microvascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11336535","citation_count":35,"is_preprint":false},{"pmid":"23323764","id":"PMC_23323764","title":"P2Y(1) knockout mice lack purinergic neuromuscular transmission in the antrum and cecum.","date":"2013","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/23323764","citation_count":35,"is_preprint":false},{"pmid":"9579787","id":"PMC_9579787","title":"Regional distribution of [35S]2'-deoxy 5'-O-(1-thio) ATP binding sites and the P2Y1 messenger RNA within the chick brain.","date":"1998","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9579787","citation_count":35,"is_preprint":false},{"pmid":"16795051","id":"PMC_16795051","title":"Mitochondrial calcium transport is regulated by P2Y1- and P2Y2-like mitochondrial receptors.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16795051","citation_count":34,"is_preprint":false},{"pmid":"16025270","id":"PMC_16025270","title":"Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application.","date":"2005","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16025270","citation_count":34,"is_preprint":false},{"pmid":"30542266","id":"PMC_30542266","title":"Astroglial Ca2+-Dependent Hyperexcitability Requires P2Y1 Purinergic Receptors and Pannexin-1 Channel Activation in a Chronic Model of Epilepsy.","date":"2018","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30542266","citation_count":33,"is_preprint":false},{"pmid":"25341729","id":"PMC_25341729","title":"Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25341729","citation_count":33,"is_preprint":false},{"pmid":"10066429","id":"PMC_10066429","title":"Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10066429","citation_count":32,"is_preprint":false},{"pmid":"26740646","id":"PMC_26740646","title":"Dual Modulation of Nociception and Cardiovascular Reflexes during Peripheral Ischemia through P2Y1 Receptor-Dependent Sensitization of Muscle Afferents.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26740646","citation_count":32,"is_preprint":false},{"pmid":"12652343","id":"PMC_12652343","title":"Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.","date":"2003","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12652343","citation_count":31,"is_preprint":false},{"pmid":"18673269","id":"PMC_18673269","title":"Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.","date":"2008","source":"Combinatorial chemistry & high throughput screening","url":"https://pubmed.ncbi.nlm.nih.gov/18673269","citation_count":31,"is_preprint":false},{"pmid":"20185765","id":"PMC_20185765","title":"The purinergic P2Y1 receptor supports leptin secretion in adipose tissue.","date":"2010","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20185765","citation_count":31,"is_preprint":false},{"pmid":"15496502","id":"PMC_15496502","title":"Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15496502","citation_count":31,"is_preprint":false},{"pmid":"18414379","id":"PMC_18414379","title":"Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors.","date":"2008","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18414379","citation_count":31,"is_preprint":false},{"pmid":"28864555","id":"PMC_28864555","title":"Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor.","date":"2017","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28864555","citation_count":30,"is_preprint":false},{"pmid":"9142866","id":"PMC_9142866","title":"Changes in P2Y1 nucleotide receptor activity during the development of rat salivary glands.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9142866","citation_count":30,"is_preprint":false},{"pmid":"24304101","id":"PMC_24304101","title":"ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice.","date":"2013","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24304101","citation_count":30,"is_preprint":false},{"pmid":"15197109","id":"PMC_15197109","title":"Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.","date":"2004","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15197109","citation_count":30,"is_preprint":false},{"pmid":"16934527","id":"PMC_16934527","title":"The enteric purinergic P2Y1 receptor.","date":"2006","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16934527","citation_count":29,"is_preprint":false},{"pmid":"22991416","id":"PMC_22991416","title":"Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands.","date":"2012","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/22991416","citation_count":29,"is_preprint":false},{"pmid":"15590415","id":"PMC_15590415","title":"Co-localization of P2Y1 receptor and NTPDase1/CD39 within caveolae in human placenta.","date":"2004","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/15590415","citation_count":28,"is_preprint":false},{"pmid":"17215444","id":"PMC_17215444","title":"P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis.","date":"2007","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/17215444","citation_count":28,"is_preprint":false},{"pmid":"8910562","id":"PMC_8910562","title":"A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910562","citation_count":28,"is_preprint":false},{"pmid":"15193995","id":"PMC_15193995","title":"2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15193995","citation_count":27,"is_preprint":false},{"pmid":"26660522","id":"PMC_26660522","title":"The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys.","date":"2016","source":"Journal of thrombosis and thrombolysis","url":"https://pubmed.ncbi.nlm.nih.gov/26660522","citation_count":27,"is_preprint":false},{"pmid":"16953187","id":"PMC_16953187","title":"Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.","date":"2006","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16953187","citation_count":27,"is_preprint":false},{"pmid":"19805741","id":"PMC_19805741","title":"Extracellular ATP inhibits chloride channels in mature mammalian skeletal muscle by activating P2Y1 receptors.","date":"2009","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19805741","citation_count":26,"is_preprint":false},{"pmid":"16543271","id":"PMC_16543271","title":"P2Y1 and P2Y2 receptor distribution varies along the human placental vascular tree: role of nucleotides in vascular tone regulation.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16543271","citation_count":26,"is_preprint":false},{"pmid":"17626796","id":"PMC_17626796","title":"Stimulation of the P2Y1 receptor up-regulates nucleoside-triphosphate diphosphohydrolase-1 in human retinal pigment epithelial cells.","date":"2007","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17626796","citation_count":26,"is_preprint":false},{"pmid":"30778022","id":"PMC_30778022","title":"MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/30778022","citation_count":25,"is_preprint":false},{"pmid":"20050186","id":"PMC_20050186","title":"P2X2, P2X4 and P2Y1 receptors elevate intracellular Ca2+ in mouse embryonic stem cell-derived GABAergic neurons.","date":"2009","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20050186","citation_count":24,"is_preprint":false},{"pmid":"25077539","id":"PMC_25077539","title":"Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25077539","citation_count":24,"is_preprint":false},{"pmid":"21310055","id":"PMC_21310055","title":"The ADP receptor P2Y1 is necessary for normal thermal sensitivity in cutaneous polymodal nociceptors.","date":"2011","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/21310055","citation_count":24,"is_preprint":false},{"pmid":"28578353","id":"PMC_28578353","title":"PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 Receptors.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28578353","citation_count":24,"is_preprint":false},{"pmid":"19741005","id":"PMC_19741005","title":"beta-Arrestin-2 interaction and internalization of the human P2Y1 receptor are dependent on C-terminal phosphorylation sites.","date":"2009","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19741005","citation_count":23,"is_preprint":false},{"pmid":"24550450","id":"PMC_24550450","title":"Central role for hydrogen peroxide in P2Y1 ADP receptor-mediated cellular responses in vascular endothelium.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24550450","citation_count":23,"is_preprint":false},{"pmid":"21879346","id":"PMC_21879346","title":"P2Y1, P2Y6, and P2Y12 receptors in rat splenic sinus endothelial cells: an immunohistochemical and ultrastructural study.","date":"2011","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21879346","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":57782,"output_tokens":7974,"usd":0.146478},"stage2":{"model":"claude-opus-4-6","input_tokens":11770,"output_tokens":4298,"usd":0.24945},"total_usd":0.395928,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures of human P2Y1R revealed two distinct ligand-binding sites: nucleotide antagonist MRS2500 binds within the seven-transmembrane bundle (orthosteric site), while non-nucleotide antagonist BPTU binds an allosteric pocket on the external receptor interface with the lipid bilayer, outside the helical bundle.\",\n      \"method\": \"X-ray crystallography at 2.7 Å (MRS2500 complex) and 2.2 Å (BPTU complex) resolution\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with two separate complexes, atomic resolution\",\n      \"pmids\": [\"25822790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and platelet shape change; selective P2Y1 antagonists (A3P5PS, A3P5P, A2P5P) blocked Ca2+ increases and shape change but not ADP-induced inhibition of adenylyl cyclase, demonstrating that P2Y1 is coupled to phospholipase C/Ca2+ signaling and is distinct from the P2TAC receptor.\",\n      \"method\": \"Pharmacological antagonism with selective antagonists in human platelets; cloning from human platelet cDNA library\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across multiple labs with orthogonal pharmacological and molecular cloning approaches\",\n      \"pmids\": [\"9442040\", \"9639511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The P2Y1 receptor is necessary to trigger ADP-induced platelet aggregation; P2Y1 selective antagonists blocked Ca2+ mobilization, shape change, and aggregation in platelets, endothelial cells, and P2Y1-transfected Jurkat cells, while having no effect on ADP-induced inhibition of adenylyl cyclase.\",\n      \"method\": \"Pharmacological antagonism in human platelets, rat brain capillary endothelial cells, and P2Y1-transfected Jurkat cells; receptor cloning and heterologous expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across multiple cell systems with selective antagonists and heterologous expression\",\n      \"pmids\": [\"9639511\", \"9442040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Purified human P2Y1 receptor, reconstituted in proteoliposomes with heterotrimeric Gαq β1γ2, stimulates steady-state GTP hydrolysis (Gq activation) upon agonist addition; agonist affinities determined directly show 2MeSADP > ADP >> ATP, and RGS4 and PLCβ1 act as GTPase-activating proteins for Gαq/Gα11 in P2Y1R-containing vesicles.\",\n      \"method\": \"Reconstitution in proteoliposomes with purified receptor and G proteins; radioligand binding with [3H]MRS2279; steady-state GTP hydrolysis assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted system with purified proteins, multiple orthogonal assays\",\n      \"pmids\": [\"14742685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Molecular dynamics simulations showed that BPTU antagonizes P2Y1R by stabilizing extracellular helix bundles and increasing lipid order, while MRS2500 blocks the ligand-binding site; ADP binding breaks an ionic lock within the receptor and forms a continuous water channel leading to receptor activation.\",\n      \"method\": \"All-atom molecular dynamics simulations (20 μs total) based on crystal structures\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method quality (structure-based) but computational only without experimental mutagenesis validation in this paper\",\n      \"pmids\": [\"27460867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2Y1 desensitization in platelets and 1321N1 cells is mediated by protein kinase C (PKC), not by GRK2 or GRK6, whereas P2Y12 desensitization is GRK-dependent; dominant-negative GRK mutants and siRNA knockdown demonstrated that GRKs phosphorylate P2Y12 but not P2Y1.\",\n      \"method\": \"Dominant-negative kinase mutant overexpression; siRNA knockdown of GRK2/GRK6; pharmacological PKC inhibition in human platelets and 1321N1 cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (dominant-negative, siRNA, pharmacology) in two cell systems\",\n      \"pmids\": [\"15665114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"P2Y1 receptor internalization and β-arrestin-2 recruitment require phosphorylation of distal C-terminal residues Ser352 and Thr358, while PKC-mediated desensitization depends on proximal C-terminal phosphorylation sites; thus receptor desensitization and internalization are mediated by distinct phosphorylation sites and kinases.\",\n      \"method\": \"Site-directed mutagenesis of phosphorylation sites; confocal microscopy of fluorescent protein-tagged receptors; ELISA-based cell-surface receptor quantification\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with multiple functional readouts\",\n      \"pmids\": [\"19741005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"After agonist-induced activation, P2Y1 sorts to lysosomes for degradation independent of direct receptor ubiquitination; this sorting is mediated by a YPX3L motif in the second intracellular loop that recruits the adaptor protein ALIX. Depletion of ALIX or mutation of the YPX3L motif inhibits P2Y1 sorting into multivesicular endosomes/lysosomes.\",\n      \"method\": \"ALIX knockdown; site-directed mutagenesis of YPX3L motif; fluorescence microscopy of GFP-tagged receptor\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus protein depletion with imaging readout\",\n      \"pmids\": [\"27301021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"P2Y1 receptor recycling after agonist-induced endocytosis occurs via a slow recycling pathway regulated by Sorting Nexin 1 (SNX1); SNX1 inhibition dramatically increases the rate of P2Y1 recycling, while inhibition of retromer components Vps26/Vps35 has no effect, demonstrating retromer-independent SNX1 regulation.\",\n      \"method\": \"SNX1 dominant-negative inhibition; siRNA knockdown of retromer components; confocal microscopy tracking of receptor trafficking\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple knockdown approaches with functional trafficking readout, single lab\",\n      \"pmids\": [\"20070609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"P2Y1 receptor mediates ADP-induced platelet shape change through Rho GTPase pathway: P2Y1 antagonism blocked cytoskeletal translocation of cdc42, rac1, and rhoA, actin polymerization, filopodia formation, and centralization of secretory granules in an integrin αIIbβ3-dependent manner.\",\n      \"method\": \"Selective P2Y1 antagonist (A2P5P) in electron microscopy and biochemical assays of platelet cytoskeletal protein translocation\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with morphological and biochemical readouts, single lab\",\n      \"pmids\": [\"11341507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ADP activates Rac GTPase and its effector PAK in platelets via the P2Y1 receptor through a Gq-dependent pathway; P2Y12 receptor alone cannot activate Rac, but secreted ADP potentiates Rac activation by other agonists via P2Y12/Gi; Gβγ subunit scavenger peptide blocked P2Y12-dependent co-activation.\",\n      \"method\": \"Selective P2Y1/P2Y12 antagonists; Rac activation pull-down assay (PAK-GST); pharmacological inhibition of Gq, Gi, PI3K; Gβγ peptide inhibitor in human platelets\",\n      \"journal\": \"Journal of thrombosis and haemostasis : JTH\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pharmacological approaches with specific biochemical readouts, single lab\",\n      \"pmids\": [\"16194206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"P2Y1 receptor couples to Rho/Rho kinase signaling in vascular myocytes: P2Y1 stimulation increases membrane-bound RhoA, promotes actin stress fiber formation inhibited by C3 exoenzyme and Y-27632 (Rho kinase inhibitor), and causes Ca2+ sensitization in aortic rings; transfection confirmed that P2Y1 subtype directly drives Rho kinase-dependent actin reorganization.\",\n      \"method\": \"Transfection of Swiss 3T3 cells with individual P2Y receptors; RhoA membrane translocation assay; C3 exoenzyme and Y-27632 pharmacology; dominant-negative RhoA expression\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative and pharmacological approaches with functional readouts\",\n      \"pmids\": [\"10843869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Metabotropic P2Y1 receptors in rat dorsal root ganglion neurons inhibit ionotropic P2X3 receptor-mediated currents; this cross-inhibition is blocked by the G protein inhibitor GDP-β-S and the P2Y1 antagonist MRS2179, but not by pertussis toxin, indicating Gαq/11 (not Gi/o) G protein mediation.\",\n      \"method\": \"Whole-cell patch-clamp recordings; selective pharmacological inhibitors; G protein inhibitors in cultured rat DRG neurons\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological dissection, single lab\",\n      \"pmids\": [\"16181623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"P2Y1 receptor activation in astrocytes triggers regulated glutamate exocytosis via Ca2+ release from internal stores; this process requires TNFα and prostaglandin E2 as co-factors, as blocking either abolishes P2Y1-evoked glutamate release. Astrocytes from TNFα-/- or TNFR1-/- mice show deficient glutamate release and altered Ca2+ signaling.\",\n      \"method\": \"Total internal fluorescence reflection imaging of labeled vesicles; Ca2+ imaging; knockout mouse astrocytes; pharmacological inhibitors; hippocampal slice recordings\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including imaging, knockout mice, and ex vivo slice recordings\",\n      \"pmids\": [\"16882655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2Y1 receptor is the post-junctional receptor mediating fast inhibitory junction potentials (fIJP) in mouse colon; P2ry1-/- mice completely lack fIJPs and purinergic contractile responses; β-NAD and ADP-ribose responses were abolished in P2ry1-/- mice, while ATP and ADP responses were retained, identifying the receptor specificity for enteric purinergic neurotransmission.\",\n      \"method\": \"Genetic knockout mice (P2ry1-/-); microelectrode recordings; pharmacological dissection; video imaging of colonic transit\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with multiple functional readouts, replicated in related studies\",\n      \"pmids\": [\"22371476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P2Y1 receptor is the general mechanism of purinergic inhibition throughout the GI tract (antrum and cecum), as confirmed in P2Y1-/- mice which lack purinergic IJPs while preserving nitrergic neurotransmission.\",\n      \"method\": \"Genetic knockout mice (P2Y1-/-); microelectrode recordings; pharmacological validation with MRS2365 and MRS2500\",\n      \"journal\": \"Neurogastroenterology and motility\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with electrophysiological functional readout\",\n      \"pmids\": [\"23323764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"P2Y1 receptor activation in hippocampal pyramidal neurons inhibits M-type K+ current (IM) and increases neuronal firing; this is blocked by the selective P2Y1 antagonist MRS2179 and by the M-channel blocker XE991, establishing P2Y1-mediated M-current inhibition as the mechanism underlying nucleotide-induced neuronal excitability.\",\n      \"method\": \"Whole-cell patch-clamp; selective P2Y1 antagonist MRS2179; immunostaining for P2Y1 in cultured rat hippocampal neurons\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with selective pharmacology, single lab\",\n      \"pmids\": [\"16957090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Astrocytic hyperactivity in an Alzheimer's disease mouse model is completely normalized by P2Y1 receptor inhibition; astroglial Ca2+ transients and waves are mediated by P2 purinoreceptors, with P2Y1R blockade (but not P2X receptor blockade) normalizing activity; nucleotide release through connexin hemichannels and increasing cortical ADP augments this hyperactivity.\",\n      \"method\": \"In vivo multiphoton Ca2+ imaging; selective P2Y1R antagonists; P2X vs P2Y pharmacological dissection in AD mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo imaging with pharmacological dissection, strong phenotypic readout\",\n      \"pmids\": [\"25406732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Microglia transform astrocytes into a neuroprotective phenotype after traumatic brain injury by secreting cytokines that downregulate P2Y1 receptor expression in astrocytes; astrocyte-specific P2Y1 overexpression counteracted scar formation while P2Y1 knockdown facilitated it, demonstrating P2Y1 as a key regulator of astrocyte phenotype switching.\",\n      \"method\": \"Astrocyte-specific P2Y1 overexpression and knockdown mouse models; in vitro injury assays; immunostaining; cytokine blocking\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary gain- and loss-of-function genetic models with mechanistic follow-up\",\n      \"pmids\": [\"28494865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RhoA signaling downstream of platelet P2Y1 receptor (not P2Y12) mediates platelet-dependent leukocyte recruitment during allergic inflammation; P2Y1 activation in platelets induces RhoA activity in vivo, and Rho kinase 1 inhibition in platelets abolished leukocyte chemotaxis, demonstrating a P2Y1-RhoA axis distinct from the P2Y12-hemostasis pathway.\",\n      \"method\": \"Selective receptor antagonists in vivo; thrombocytopenic mice reconstituted with pharmacologically pretreated platelets; flow cytometry; RhoA activity assay\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo platelet reconstitution with functional readout, single lab\",\n      \"pmids\": [\"25445826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"P2Y1 receptor mediates ADP-induced generation of a p38 MAP kinase-activating factor in human platelets via an aspirin-sensitive pathway; selective P2Y1 antagonist A2P5P inhibited this response while P2TAC and P2X1 antagonists had no effect.\",\n      \"method\": \"Selective pharmacological antagonists; p38 MAP kinase activation assay in human platelets\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with biochemical kinase activity readout, single lab\",\n      \"pmids\": [\"10759852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Electrical stimulation of skeletal muscle triggers ROS production via a P2Y1-PKC-NOX2 pathway; extracellular ATP released from muscle activates P2Y1 receptors (MRS2365 mimics effect; P2Y1 antagonist MRS2179 blocks it), leading to PKC-dependent NOX2 activation and H2O2 production.\",\n      \"method\": \"Selective P2Y1 agonist and antagonist; fluorescent ROS probes; NOX2 and PKC inhibitors in skeletal muscle fibers and isolated muscle fibres\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with functional ROS readout, single lab\",\n      \"pmids\": [\"26053483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ADP activation of P2Y1 receptor in endothelial cells produces H2O2-dependent phosphorylation of eNOS, AMPK, MARCKS, and c-Abl; H2O2 mediates downstream Rac1-dependent AMPK and CrkII signaling; P2Y1 activation also transactivates the receptor tyrosine kinase Flt3. ADP-stimulated H2O2 increases were localized to cytosol and caveolae.\",\n      \"method\": \"PEG-catalase H2O2 scavenger; FRET-based Rac1 and H2O2 biosensors (HyPer2) with subcellular targeting; receptor tyrosine kinase screen; pharmacological inhibitors in endothelial cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biosensor and scavenger approaches, single lab\",\n      \"pmids\": [\"24550450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Membrane depolarization directly potentiates P2Y1 receptor-evoked IP3-dependent Ca2+ mobilization in megakaryocytes, revealing voltage-dependence of this Gq-coupled GPCR; depolarization can also stimulate Ca2+ release in the presence of competitive antagonists, indicating a novel coincidence detection mechanism.\",\n      \"method\": \"Simultaneous whole-cell patch-clamp and fura-2 fluorescence in rat megakaryocytes; voltage protocols with multiple agonists and antagonists\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology combined with Ca2+ imaging, single lab\",\n      \"pmids\": [\"18414379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The cloned human P2Y1 receptor, when stably expressed in 1321N1 astrocytoma cells, activates phospholipase C/inositol phosphate signaling in response to ADP and 2-methylthioATP; adenosine bisphosphate derivatives (A3P5PS, A3P5P, A2P5P) act as competitive antagonists of this receptor without affecting P2Y2, P2Y4, or P2Y6 receptors.\",\n      \"method\": \"Heterologous expression; inositol phosphate accumulation assay; Schild analysis of competitive antagonism\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — heterologous expression with quantitative pharmacological characterization, replicated across labs\",\n      \"pmids\": [\"8913364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NTPDase1 (hydrolyzes both NTPs and NDPs) reduces P2Y1 receptor signaling by degrading agonist ADP, while NTPDase2 (preferentially hydrolyzes NTPs) converts ATP to ADP, thereby increasing basal P2Y1 receptor activity; co-expression or co-culture of these ectonucleotidases differentially modulates the EC50 for P2Y1 receptor agonists.\",\n      \"method\": \"Co-expression and co-culture of P2Y1R with NTPDase1 or NTPDase2 in cell lines; inositol phosphate accumulation assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell co-expression and co-culture approaches with functional readout, single lab\",\n      \"pmids\": [\"15496502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"P2Y1 receptor and NTPDase1/CD39 are co-localized within caveolae of human placental endothelial cells, suggesting that the ectonucleotidase directly controls local nucleotide concentration and P2Y1 receptor activation at these membrane microdomains.\",\n      \"method\": \"Immunohistochemistry and immunogold electron microscopy of human placental tissue\",\n      \"journal\": \"European journal of histochemistry : EJH\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — co-localization by immunomicroscopy without functional validation of the microdomains\",\n      \"pmids\": [\"15590415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"P2Y1 receptor activation induces apoptosis and inhibits proliferation of PC-3 prostate cancer cells through the MAP kinase pathway; selective P2Y1 agonist MRS2365 activated caspase-3 and increased LDH release, effects blocked by P2Y1 antagonist MRS2500, P2Y1 siRNA, and the MAP kinase inhibitor PD98059.\",\n      \"method\": \"Selective agonist/antagonist; siRNA knockdown; caspase-3 assay; LDH release; annexin-V staining; MTT proliferation assay in PC-3 cells\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological, genetic, and biochemical approaches with multiple death readouts\",\n      \"pmids\": [\"21632028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Transgenic mice overexpressing P2Y1 receptor specifically in megakaryocytes/platelets (84% increase in receptor density) display platelet hyper-reactivity: enhanced aggregation to ADP and low-dose collagen, ADP-induced granule secretion (not seen in wild-type), shortened bleeding time, and increased sensitivity to in vivo thromboembolism.\",\n      \"method\": \"Platelet-lineage-specific transgenic overexpression; saturation binding assay; aggregometry; in vivo thromboembolism model\",\n      \"journal\": \"Journal of thrombosis and haemostasis : JTH\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic gain-of-function model with multiple in vitro and in vivo functional readouts\",\n      \"pmids\": [\"12871553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"P2Y1 receptor is required for normal thermal sensitivity in cutaneous polymodal nociceptors (CPMs); P2Y1-/- mice show increased mean heat threshold and decreased peak firing during thermal ramps, and altered cold threshold, without changes in mechanical sensitivity.\",\n      \"method\": \"Genetic knockout mice (P2Y1-/-); ex vivo electrophysiological recordings from skin-nerve-DRG preparation with calibrated thermal stimuli\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with specific ex vivo electrophysiological readout, single lab\",\n      \"pmids\": [\"21310055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Uridine adenosine tetraphosphate (Up4A) is a potent native agonist for P2Y1R and small-conductance K+ (SK) channel activation in human and mouse colon; Up4A-induced relaxation and hyperpolarization were blocked by the P2Y1R antagonist MRS2500 and were absent in P2ry1-/- mice, and Up4A responses are not mediated by its metabolites.\",\n      \"method\": \"Selective P2Y1R antagonist MRS2500; P2ry1-/- genetic knockout mice; electrophysiology; Ca2+ imaging in P2Y1R-expressing astrocytoma cells; HPLC for metabolite analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacology, genetic knockout, and direct biochemical approaches across multiple preparations\",\n      \"pmids\": [\"25341729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ATP released from skeletal muscle during electrical stimulation inhibits chloride channels via P2Y1 receptors: the P2Y1-selective agonist 2MeSADP (EC50 ~160 nM) increased input resistance and prolonged mEPP falling phase; these effects were blocked by the P2Y1 antagonist MRS2179 and anthracene-9-carboxylic acid (Cl- channel blocker).\",\n      \"method\": \"Intracellular microelectrode recordings in innervated rat muscle; selective P2Y1 agonist and antagonist; chloride channel pharmacology\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with selective pharmacological dissection, single lab\",\n      \"pmids\": [\"19805741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"P2Y12 receptor (not P2Y1) is involved in thrombin-induced phosphatidylserine exposure on platelets and subsequent thrombin generation in platelet-rich plasma; P2Y1 is not involved in procoagulant activity, but both receptors contribute to platelet-leukocyte interactions mediated by P-selectin exposure.\",\n      \"method\": \"Selective P2Y1 (MRS2179) and P2Y12 (AR-C69931MX) antagonists; flow cytometry for PS exposure; thrombin generation assay; P-selectin assay in human platelets\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with selective antagonists and multiple functional assays, single lab\",\n      \"pmids\": [\"12933533\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P2Y1R is a Gq-coupled GPCR activated by extracellular ADP (and other nucleotides like Up4A) that signals through phospholipase C to mobilize intracellular Ca2+ and activate downstream effectors including PKC, Rac GTPase, RhoA/Rho-kinase, p38 MAPK, and H2O2-dependent pathways; crystal structures reveal two distinct ligand-binding sites (an orthosteric transmembrane site and an allosteric exterior lipid-bilayer interface), receptor desensitization is controlled by PKC phosphorylation of proximal C-terminal sites, internalization by GRK-independent phosphorylation of distal C-terminal residues Ser352/Thr358 and β-arrestin-2 recruitment, and lysosomal degradation via ALIX/YPX3L motif; physiologically, P2Y1R is essential for ADP-induced platelet shape change, Ca2+ mobilization, and aggregation, mediates fast inhibitory purinergic neuromuscular transmission in the GI tract, regulates astrocyte Ca2+ dynamics and phenotype switching in the brain, modulates thermal nociception in sensory neurons, and controls M-current and neuronal excitability in hippocampal neurons.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"P2RY1 encodes a Gq-coupled purinergic receptor activated by extracellular ADP and uridine adenosine tetraphosphate (Up4A) that signals through phospholipase C to mobilize intracellular Ca2+ and engage downstream effectors including PKC, RhoA/Rho kinase, Rac GTPase, p38 MAPK, and H2O2-dependent pathways [PMID:9442040, PMID:14742685, PMID:10843869, PMID:24550450, PMID:25341729]. Crystal structures reveal two pharmacologically distinct antagonist-binding sites—an orthosteric pocket within the transmembrane bundle and an allosteric site at the receptor–lipid bilayer interface—while receptor desensitization is controlled by PKC phosphorylation of proximal C-terminal residues and internalization requires GRK-independent phosphorylation of Ser352/Thr358 with β-arrestin-2 recruitment, followed by ALIX/YPX3L motif–dependent lysosomal sorting [PMID:25822790, PMID:15665114, PMID:19741005, PMID:27301021]. Physiologically, P2RY1 is essential for ADP-induced platelet shape change and aggregation, mediates fast inhibitory purinergic neurotransmission throughout the gastrointestinal tract, regulates astrocyte Ca2+ dynamics and phenotype switching in the brain, modulates thermal nociception in sensory neurons, and controls M-current–dependent neuronal excitability in hippocampal neurons [PMID:9639511, PMID:22371476, PMID:25406732, PMID:28494865, PMID:21310055, PMID:16957090].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identifying that the cloned human P2Y1 receptor couples to phospholipase C/inositol phosphate signaling upon ADP stimulation, and that adenosine bisphosphate derivatives serve as selective competitive antagonists, established the receptor's pharmacological identity and Gq-PLC coupling.\",\n      \"evidence\": \"Heterologous expression in 1321N1 astrocytoma cells with inositol phosphate accumulation and Schild analysis\",\n      \"pmids\": [\"8913364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous cellular functions not yet demonstrated\", \"G protein specificity not directly tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that P2Y1 mediates ADP-induced Ca2+ mobilization, platelet shape change, and aggregation—while having no role in adenylyl cyclase inhibition—resolved the long-standing question of which receptor subtype drives the initial phase of platelet activation and separated P2Y1 from the P2TAC/P2Y12 pathway.\",\n      \"evidence\": \"Selective P2Y1 antagonists in human platelets, endothelial cells, and P2Y1-transfected Jurkat cells; platelet cDNA cloning\",\n      \"pmids\": [\"9442040\", \"9639511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Knockout validation not yet available\", \"Signaling intermediates between Gq and cytoskeletal reorganization uncharacterized\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that P2Y1 couples to RhoA/Rho kinase–dependent actin remodeling and to p38 MAPK activation in platelets and vascular myocytes expanded the downstream signaling repertoire beyond PLC/Ca2+ to include cytoskeletal and stress kinase pathways.\",\n      \"evidence\": \"Transfection of individual P2Y receptors in Swiss 3T3 cells; RhoA membrane translocation; dominant-negative RhoA; Rho kinase inhibitor pharmacology; p38 MAPK activity in human platelets\",\n      \"pmids\": [\"10843869\", \"10759852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical link between Gαq and RhoA activation not delineated\", \"p38 activation mechanism (aspirin-sensitive factor) not molecularly identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that P2Y1 antagonism blocks ADP-induced translocation of Cdc42, Rac1, and RhoA to the platelet cytoskeleton along with filopodia formation linked the receptor to the full Rho-family GTPase cascade governing platelet shape change.\",\n      \"evidence\": \"Electron microscopy and biochemical cytoskeletal fractionation with selective P2Y1 antagonist in human platelets\",\n      \"pmids\": [\"11341507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integrin dependence versus independence of each GTPase step unclear\", \"No genetic loss-of-function confirmation\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Platelet-lineage-specific P2Y1 transgenic overexpression causing hyper-reactivity, enhanced aggregation, granule secretion, shortened bleeding time, and increased thromboembolism provided the first genetic gain-of-function proof that P2Y1 receptor density directly controls thrombotic risk in vivo.\",\n      \"evidence\": \"Megakaryocyte/platelet-specific transgenic mice; saturation binding; aggregometry; in vivo thromboembolism model\",\n      \"pmids\": [\"12871553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corresponding loss-of-function platelet phenotype not shown in this study\", \"Whether increased receptor density shifts agonist preference unexamined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Reconstituting purified P2Y1R with Gαq/β1γ2 in proteoliposomes and measuring agonist-stimulated GTP hydrolysis provided direct biochemical proof of Gq coupling, established the intrinsic agonist rank order (2MeSADP > ADP >> ATP), and showed RGS4 and PLCβ1 function as GAPs for Gαq in this system.\",\n      \"evidence\": \"Purified receptor reconstitution in proteoliposomes; radioligand binding; steady-state GTPase assay\",\n      \"pmids\": [\"14742685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of agonist selectivity not resolved\", \"Other potential G protein couplings not tested in reconstituted system\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Dissecting P2Y1 desensitization as PKC-dependent (not GRK-dependent) using dominant-negative GRKs and siRNA, in contrast to GRK-dependent P2Y12 desensitization, established that the two platelet ADP receptors use fundamentally different regulatory mechanisms.\",\n      \"evidence\": \"Dominant-negative GRK2/GRK6 overexpression; GRK siRNA knockdown; PKC inhibitors in platelets and 1321N1 cells\",\n      \"pmids\": [\"15665114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PKC isoform responsible not identified\", \"Phosphorylation sites mediating PKC desensitization not mapped\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that P2Y1 activates Rac GTPase and PAK through Gq while P2Y12 potentiates this via Gi/Gβγ resolved how two ADP receptors cooperate to achieve full small GTPase activation during platelet signaling.\",\n      \"evidence\": \"Selective P2Y1/P2Y12 antagonists; Rac-GTP pull-down; Gβγ scavenger peptide in human platelets\",\n      \"pmids\": [\"16194206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intermediate between Gαq and Rac guanine nucleotide exchange factor not identified\", \"Relative contributions to platelet spreading versus aggregation unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Finding that P2Y1 activation in astrocytes triggers Ca2+-dependent glutamate exocytosis requiring TNFα and prostaglandin E2 as co-factors, and that P2Y1 inhibits M-type K+ current in hippocampal neurons to increase excitability, established two distinct neuronal circuit–level roles for P2Y1 signaling in the brain.\",\n      \"evidence\": \"TIRFM vesicle imaging and Ca2+ imaging in astrocytes from TNFα−/− and TNFR1−/− mice; whole-cell patch-clamp with MRS2179 in hippocampal neurons\",\n      \"pmids\": [\"16882655\", \"16957090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the gliotransmitter release machinery downstream of Ca2+ not fully defined\", \"Whether M-current modulation occurs in vivo not shown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapping P2Y1 internalization to distal C-terminal phosphorylation sites Ser352/Thr358 and β-arrestin-2 recruitment—distinct from the proximal PKC sites controlling desensitization—demonstrated that functional uncoupling and endocytic removal are mechanistically separable regulatory events.\",\n      \"evidence\": \"Site-directed mutagenesis; confocal microscopy of fluorescent-tagged receptor; ELISA-based surface quantification\",\n      \"pmids\": [\"19741005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The kinase phosphorylating Ser352/Thr358 not identified (shown to be GRK-independent)\", \"β-arrestin-2 binding determinants on receptor not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying SNX1 as a retromer-independent regulator of P2Y1 slow recycling revealed a non-canonical post-endocytic trafficking pathway for this receptor.\",\n      \"evidence\": \"SNX1 dominant-negative inhibition; siRNA knockdown of retromer components; confocal receptor tracking\",\n      \"pmids\": [\"20070609\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which SNX1 retards recycling not defined\", \"Not validated in endogenous P2Y1-expressing primary cells\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Complete loss of fast inhibitory junction potentials in P2ry1−/− mouse colon, and extension to antrum and cecum, established P2Y1 as the obligate post-junctional receptor for purinergic inhibitory neuromuscular transmission throughout the gastrointestinal tract, with β-NAD and ADP-ribose (not ATP) as likely endogenous transmitters.\",\n      \"evidence\": \"P2ry1−/− knockout mice; microelectrode recordings; pharmacological dissection; video imaging of colonic transit\",\n      \"pmids\": [\"22371476\", \"23323764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous purinergic neurotransmitter identity debated (β-NAD vs. ADP-ribose)\", \"Mechanism of SK channel coupling downstream of P2Y1 in smooth muscle not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multiple 2014 studies expanded the physiological scope: Up4A was identified as a potent endogenous P2Y1 agonist for enteric inhibitory neurotransmission; P2Y1-RhoA signaling in platelets was shown to drive leukocyte recruitment in allergic inflammation; P2Y1-mediated H2O2 production was established as a second messenger activating AMPK, Rac1, and Flt3 transactivation in endothelial cells; and P2Y1 blockade normalized astrocytic hyperactivity in an Alzheimer's disease mouse model.\",\n      \"evidence\": \"P2ry1−/− mice with electrophysiology and HPLC; platelet reconstitution in thrombocytopenic mice; FRET-based H2O2/Rac1 biosensors in endothelial cells; in vivo multiphoton Ca2+ imaging in AD model\",\n      \"pmids\": [\"25341729\", \"25445826\", \"24550450\", \"25406732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of Up4A in enteric nervous system not identified\", \"Whether H2O2-dependent signaling occurs in platelets or only endothelium unknown\", \"Causal relationship between P2Y1 and Alzheimer's pathogenesis not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of P2Y1R bound to a nucleotide antagonist (orthosteric) and a non-nucleotide antagonist (allosteric, at the lipid-bilayer interface) revealed two pharmacologically distinct binding sites, providing the first atomic-resolution framework for structure-based drug design targeting this receptor class.\",\n      \"evidence\": \"X-ray crystallography at 2.7 Å and 2.2 Å resolution\",\n      \"pmids\": [\"25822790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No agonist-bound or active-state structure available\", \"Structural basis for Gq selectivity not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying the ALIX-binding YPX3L motif in the second intracellular loop as required for ubiquitin-independent lysosomal sorting completed the post-endocytic trafficking itinerary from internalization through degradation.\",\n      \"evidence\": \"ALIX knockdown; YPX3L motif mutagenesis; GFP-tagged receptor fluorescence microscopy\",\n      \"pmids\": [\"27301021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether lysosomal sorting is the dominant degradation route in primary cells not confirmed\", \"Interaction between SNX1-recycling and ALIX-degradation pathways not examined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that microglial cytokines downregulate astrocytic P2Y1 to promote scar formation after brain injury, with P2Y1 overexpression counteracting and knockdown facilitating scarring, established P2Y1 as a central switch governing astrocyte phenotype in neuroinflammation.\",\n      \"evidence\": \"Astrocyte-specific P2Y1 overexpression and knockdown mouse models; in vitro injury assays; cytokine blocking\",\n      \"pmids\": [\"28494865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional program controlled by P2Y1 in reactive astrocytes not mapped\", \"Whether this mechanism operates in chronic neurodegenerative disease unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No agonist-bound active-state structure of P2Y1R exists, the kinase phosphorylating the distal C-terminal internalization sites remains unidentified, the precise endogenous purinergic neurotransmitter at enteric P2Y1 receptors is debated, and the structural basis for Gq selectivity over other G proteins has not been determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active-state crystal or cryo-EM structure needed\", \"Identity of kinase for Ser352/Thr358 phosphorylation unknown\", \"Endogenous enteric neurotransmitter (β-NAD, ADP-ribose, or Up4A) not definitively established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 2, 3, 24, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 6, 26]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 3, 11, 12, 24]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [1, 2, 9, 10, 28]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [14, 15, 16, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNA11\",\n      \"GNAQ\",\n      \"ARRB2\",\n      \"ALIX\",\n      \"SNX1\",\n      \"RHOA\",\n      \"RAC1\",\n      \"PLCB1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}